Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4184.00 +0.3% SILVER 57.27 +0.2% COPPER 6.57 +0.2% OIL 98.64 +0.7% PALLADIUM 1116.25 −1.1% MON 0.385 −6.1% OMI 0.250 +0.0% BUFF 0.800 +2.6% FEO 0.650 +0.0% LIB 0.700 −2.8% NPR 0.620 +0.0% QZM 0.380 +0.0% BVA 0.770 +1.3% ONAU 0.530 +1.9% FMR 0.225 +0.0% GSVR 0.350 +2.9% PHNM 0.345 +1.5% SLG 5.54 −3.0% CASA 0.060 +0.0% DRY 0.220 +2.3% SOMA 0.570 +1.8% GOLD 4184.00 +0.3% SILVER 57.27 +0.2% COPPER 6.57 +0.2% OIL 98.64 +0.7% PALLADIUM 1116.25 −1.1% MON 0.385 −6.1% OMI 0.250 +0.0% BUFF 0.800 +2.6% FEO 0.650 +0.0% LIB 0.700 −2.8% NPR 0.620 +0.0% QZM 0.380 +0.0% BVA 0.770 +1.3% ONAU 0.530 +1.9% FMR 0.225 +0.0% GSVR 0.350 +2.9% PHNM 0.345 +1.5% SLG 5.54 −3.0% CASA 0.060 +0.0% DRY 0.220 +2.3% SOMA 0.570 +1.8%

Healthcare

Page 60
  1. Feb 17, 2026 · 18:29 · BCT

    Briacell receives recommendation from safety board

    Briacell receives recommendation from safety board

    01
  2. Feb 17, 2026 · 17:52 · SPLY

    Safe Supply to sell two Nirlab devices to first nation

    Safe Supply to sell two Nirlab devices to first nation

    02
  3. Feb 17, 2026 · 17:50 · KNE

    Kane Biotech passes regulatory "milestones"

    Kane Biotech passes regulatory "milestones"

    03
  4. Feb 17, 2026 · 17:40 · TLT

    Theralase to present bladder cancer data set at EAU26

    Theralase to present bladder cancer data set at EAU26

    04
  5. Feb 17, 2026 · 11:33 · BNXT

    Bionxt obtains European patent for MS drug tech

    Bionxt obtains European patent for MS drug tech

    05
  6. Feb 17, 2026 · 09:00 · GSD

    Devonian Advances Thykamine(TM) Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls

    Devonian Advances Thykamine(TM) Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls

    06
  7. Feb 17, 2026 · 08:00 · ZCT

    Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device

    Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device

    07
  8. Feb 17, 2026 · 07:30 · BCT

    BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

    BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

    08
  9. Feb 17, 2026 · 07:30 · HELP

    Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder

    Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder

    09
  10. Feb 17, 2026 · 07:25 · KNE

    Kane Biotech Announces FDA 510(k) Clearance for revyve(TM) Antimicrobial Skin and Wound Cleanser

    Kane Biotech Announces FDA 510(k) Clearance for revyve(TM) Antimicrobial Skin and Wound Cleanser

    10
  11. Feb 17, 2026 · 07:02 · TLT

    Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress

    Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress

    11
  12. Feb 17, 2026 · 03:05 · BNXT

    BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis

    BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis

    12
  13. Feb 13, 2026 · 15:24 · MDNA

    Medicenna's Dec. 31 cash at $10.6 million

    Medicenna's Dec. 31 cash at $10.6 million

    13
  14. Feb 13, 2026 · 13:27 · HELP

    Cybin's Dec. 31 cash at $195.1-million (U.S.)

    Cybin's Dec. 31 cash at $195.1-million (U.S.)

    14
← Newer Older →